Rhabdomyolysis Clinical Trial
Official title:
Is Rhabdomyolysis an Anesthetic Complication in Patients Undergoing Robot-assisted Radical Prostatectomy?
In patients undergoing robot-assisted radical prostatectomy (RARP), pneumoperitoneum,
intraoperative fluid restriction and prolonged Trendelenburg position may cause
rhabdomyolysis (RM) due to hypoperfusion in gluteal muscles and lower extremities.
In this study, it was aimed to assess effects of BMI, comorbidities, intraoperative
positioning, fluid restriction and length of surgery on development of RM in RARP patients
during perioperative period.
Fifty-two ASA I-II patients aged 50-80 years, BMI >25 kg/m2 scheduled for an elective RARP
were enrolled to the study.
In all patients, pre-anesthetic evaluations including laboratory tests and Charlson
Comorbidity Index (CCI) were performed one week before surgery in anesthesia clinic.
Comorbid diseases were rated based on CCI. A 4-points scale was used to rate comorbid
conditions [1 mild; 4 severe]. Comorbidity grading was performed by adding scores given for
each comorbid disease. Based on the grading, patients were stratified into 4 groups as
follows: grade 0, 1-2, 3-4 and ≥ 5
In the operation room, intubation was performed after standard anesthesia For surgery,
patients were placed in low lithotomy position. All patients were placed on a soft sponge
mattress and soft padding gel pads were provided above the shoulders. The patients were
placed in a 30-degree STP after achieving pneumoperitoneum at an intra-abdominal pressure
level of 15 mmHg. After placing patient to desired position (T0), blood samples were drawn
for measurements of ABG, Na, Cl, Ca, K, BUN, Cr, AST, ALT, LDH, cTp-I, CK-MB and CPK.
During the operation, normal saline (1 m/kg/hr) and 6% HES 200/05 (1 ml/kg/hr) infusions
were applied. Operation time (OT) and Trendelenburg time (TT) were recorded in all patients.
Blood samples were repeated on the hours 6 (T6), 12 (T12) and 24 (T24) after beginning of
surgery. Hydration with 2000 ml crystalloid solution was given until hour 24 after surgery.
In all patients, urine output was monitored.
Rhabdomyolysis was defined as postoperative serum CPK level exceeding 5,000 IU/L. It was
planned to manage these patients with hypervolemic therapy, correction of acidosis by using
IV sodium bicarbonate and stimulation of diuresis by IV furosemide with a goal of
maintaining minimal diuresis of 60 ml/hr at pH level of 7.
Postoperative RF was defined as an increase in serum creatinine of 1mg/dl/day (or 90
mmol/l/day) for 2 consecutive days beyond the baseline.
Patients were discharged with control laboratory tests, including the same parameters, on
the hour 48 (T48) postoperatively.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03737513 -
Exercise-induced Collective Rhabdomyolysis
|
||
Completed |
NCT00241748 -
Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event
|
N/A | |
Not yet recruiting |
NCT02498366 -
Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty
|
N/A | |
Not yet recruiting |
NCT06429982 -
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
|
Phase 1 | |
Active, not recruiting |
NCT06101680 -
RhabdomYolyse in Intensive caRe
|
||
Withdrawn |
NCT02896517 -
Support for the Rhabdomyolysis in an Emergency Department
|
||
Completed |
NCT01467180 -
Myoglobin Removal by High Cut-off CVVHD
|
N/A | |
Recruiting |
NCT01022450 -
Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
|
N/A | |
Completed |
NCT00391911 -
Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis
|
Phase 2 | |
Withdrawn |
NCT02111018 -
Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
|
Phase 2 | |
Completed |
NCT04913298 -
Prospective Study for the Application of Cytosorb® in Critically Ill Patients
|
N/A | |
Recruiting |
NCT05146336 -
CytOSorb TreatMent Of Critically Ill PatientS Registry
|
||
Completed |
NCT03986736 -
Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
|
||
Not yet recruiting |
NCT02518724 -
The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis
|
N/A | |
Completed |
NCT00592657 -
Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions
|
N/A | |
Completed |
NCT06338423 -
Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure
|
N/A | |
Completed |
NCT01976936 -
Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
|
Phase 2 | |
Completed |
NCT04118608 -
Rhabdomyolysis - a Study of Patient Characteristics and Laboratory Values to Guide Treatment
|
||
Completed |
NCT01544231 -
Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis
|
N/A | |
Recruiting |
NCT00549029 -
The Association of Genetic Polymorphisms With Statin-Induced Myopathy.
|
N/A |